XML 110 R102.htm IDEA: XBRL DOCUMENT v2.4.0.8
Schedule I - Condensed Financial Information of Registrant (Condensed Statements of Comprehensive Income) (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 12 Months Ended
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Dec. 31, 2012
Sep. 30, 2012
Jun. 30, 2012
Mar. 31, 2012
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Condensed Financial Statements, Captions [Line Items]                      
Net income $ 19,800 $ 66,800 [1] $ 33,500 $ 50,100 [2] $ 6,000 [3],[4] $ 18,000 [5] $ 124,600 [6] $ (26,600) [7] $ 170,126 $ 122,063 $ 72,120
Unrealized (losses) gains on investments available-for-sale:                      
Unrealized holding (losses) gains arising during the period                 (78,217) 65,462 54,607
Less: Reclassification adjustments for gains included in earnings                 (23,975) (36,680) (33,029)
Unrealized gains on investments available-for-sale, net                 (102,192) 28,782 21,578
Defined benefit pension plans:                      
Prior service cost arising during the period                 607 0 (1,304)
Net gain (loss) arising during the period                 7,294 (646) (12,904)
Less: Amortization of prior service cost and net loss included in net periodic pension cost                 2,572 4,152 628
Defined benefit pension plans, net                 10,473 3,506 (13,580)
Other comprehensive (loss) income, before tax                 (91,719) 32,288 7,998
Income tax (benefit) expense related to components of other comprehensive income                 (31,868) 21,936 (8,147)
Other comprehensive income, net of tax                 (59,851) 10,352 16,145
Comprehensive income                 110,275 132,415 88,265
Parent Company [Member]
                     
Condensed Financial Statements, Captions [Line Items]                      
Net income                 170,126 122,063 72,120
Unrealized (losses) gains on investments available-for-sale:                      
Unrealized holding (losses) gains arising during the period                 (78,217) 65,462 54,607
Less: Reclassification adjustments for gains included in earnings                 (23,975) (36,680) (33,029)
Unrealized gains on investments available-for-sale, net                 (102,192) 28,782 21,578
Defined benefit pension plans:                      
Prior service cost arising during the period                 607 0 (1,304)
Net gain (loss) arising during the period                 7,294 (646) (12,904)
Less: Amortization of prior service cost and net loss included in net periodic pension cost                 2,572 4,152 628
Defined benefit pension plans, net                 10,473 3,506 (13,580)
Other comprehensive (loss) income, before tax                 (91,719) 32,288 7,998
Income tax (benefit) expense related to components of other comprehensive income                 (31,868) 21,936 (8,147)
Other comprehensive income, net of tax                 (59,851) 10,352 16,145
Comprehensive income                 $ 110,275 $ 132,415 $ 88,265
[1] Includes $32.1 million of Medicaid premium revenue as a result of Medicaid/Medi-Cal retroactive rate adjustments for periods prior to 2013.
[2] Includes $42.2 million of Medicaid premium revenue as a result of Medicaid/Medi-Cal retroactive rate adjustments related to 2011 and 2012.
[3] Includes a $2.2 million unfavorable adjustment to the gain on sale of discontinued operation, an $8.2 million expense related to our G&A cost reduction efforts, a $5.0 million expense related to the early termination of a medical management contract and $7.1 million of litigation-related expenses.
[4] Includes $31.5 million of premium revenue as a result of Medicaid/Medi-Cal retroactive rate adjustment related to the third quarter of 2012 and prior periods.
[5] Includes a $2.4 million unfavorable adjustment to the gain on sale of discontinued operation and a $7.2 million expense related to our G&A cost reduction efforts.
[6] Includes $119.4 million gain on sale of discontinued operation related to the sale of our Medicare PDP business to CVS Caremark. Also includes $7.9 million of adverse development related to prior years recorded as part of health care costs, and a $10.8 million expense related to our G&A cost reduction efforts.
[7] Includes $25.0 million of adverse development related to prior periods recorded as part of health care costs, a $9.5 million expense related to our G&A cost reduction efforts and an unfavorable $0.7 million in pretax litigation reserve adjustment. Also includes a $6.5 million insurance reimbursement related to a prior legal settlement.